Free Trial

Core Laboratories Q3 2024 Earnings Report

Core Laboratories logo
$16.12 -0.75 (-4.42%)
As of 02/21/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Core Laboratories EPS Results

Actual EPS
$0.25
Consensus EPS
$0.21
Beat/Miss
Beat by +$0.04
One Year Ago EPS
$0.22

Core Laboratories Revenue Results

Actual Revenue
$134.40 million
Expected Revenue
$134.16 million
Beat/Miss
Beat by +$240.00 thousand
YoY Revenue Growth
+7.20%

Core Laboratories Announcement Details

Quarter
Q3 2024
Time
After Market Closes

Core Laboratories Earnings Headlines

Core Laboratories price target raised to $15 from $14 at Citi
The FED is losing the war on inflation
It's no longer just a “guesstimate” – Inflation is indeed getting worse. And although we want to believe the Fed has a good grip on it, they don't. Right now, the suits over there are caught between a rock and a hard place. Either they watch as inflation grows, or they tear it down and send us into a full-blown recession. The kicker here is that neither of these are good for you. Whichever pill we end up with, prices will still climb higher as the value of the dollar sinks lower. The only real way out for the regular person is to increase your earning power. By increasing your income to match prices as they flare up… You’ll stay ahead of the impending doom we're running face-first into. And if you're looking for a strategy to help increase your income in 2025… I've got just the thing for you! You see, last year, I was able to grow a $10k model account to a little over $63k with 100 trade alerts But I changed my trading rules and more than doubled my results on those 100 published trades. I'm now calling them Warped Options…
Stifel Nicolaus Remains a Hold on Core Laboratories (CLB)
See More Core Laboratories Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Core Laboratories? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Core Laboratories and other key companies, straight to your email.

About Core Laboratories

Core Laboratories (NYSE:CLB) provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.

View Core Laboratories Profile

More Earnings Resources from MarketBeat